These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 20056543)

  • 41. Anti-tumor and anti-angiogenic activity of novel hydantoin derivatives: Inhibition of VEGF secretion in liver metastatic osteosarcoma cells.
    Basappa ; Ananda Kumar CS; Nanjunda Swamy S; Sugahara K; Rangappa KS
    Bioorg Med Chem; 2009 Jul; 17(14):4928-34. PubMed ID: 19556138
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antitumor-promoting effects of new sesquiterpenes from Crossopetalum tonduzii.
    Mendoza CR; Jiménez IA; Tokuda H; Kushida H; Bazzocchi IL
    Chem Biodivers; 2005 Feb; 2(2):286-94. PubMed ID: 17191981
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase.
    Kim YM; Jang JW; Lee OH; Yeon J; Choi EY; Kim KW; Lee ST; Kwon YG
    Cancer Res; 2000 Oct; 60(19):5410-3. PubMed ID: 11034081
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-angiogenic function of tocotrienol.
    Miyazawa T; Shibata A; Nakagawa K; Tsuzuki T
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():253-6. PubMed ID: 18296349
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of noreremophilane-based inhibitors of angiogenesis using zebrafish assays.
    Muthukumarasamy KM; Handore KL; Kakade DN; Shinde MV; Ranjan S; Kumar N; Sehrawat S; Sachidanandan C; Reddy DS
    Org Biomol Chem; 2016 Feb; 14(5):1569-78. PubMed ID: 26483278
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Study of puupehenone and related compounds as inhibitors of angiogenesis.
    Castro ME; González-Iriarte M; Barrero AF; Salvador-Tormo N; Muñoz-Chápuli R; Medina MA; Quesada AR
    Int J Cancer; 2004 May; 110(1):31-8. PubMed ID: 15054866
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular insight in the multifunctional activities of Withaferin A.
    Vanden Berghe W; Sabbe L; Kaileh M; Haegeman G; Heyninck K
    Biochem Pharmacol; 2012 Nov; 84(10):1282-91. PubMed ID: 22981382
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The antitumor activity of naturally occurring chromones: A review.
    Duan YD; Jiang YY; Guo FX; Chen LX; Xu LL; Zhang W; Liu B
    Fitoterapia; 2019 Jun; 135():114-129. PubMed ID: 31029639
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chemistry and biology of acylfulvenes: sesquiterpene-derived antitumor agents.
    Tanasova M; Sturla SJ
    Chem Rev; 2012 Jun; 112(6):3578-610. PubMed ID: 22482429
    [No Abstract]   [Full Text] [Related]  

  • 50. Natural products as anti-invasive and anti-metastatic agents.
    Jiang YL; Liu ZP
    Curr Med Chem; 2011; 18(6):808-29. PubMed ID: 21182481
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pleiotropic Role of Puupehenones in Biomedical Research.
    Martínez-Poveda B; Quesada AR; Medina MÁ
    Mar Drugs; 2017 Oct; 15(10):. PubMed ID: 29065486
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-angiogenic activities of gliotoxin and its methylthioderivative, fungal metabolites.
    Lee HJ; Lee JH; Hwang BY; Kim HS; Lee JJ
    Arch Pharm Res; 2001 Oct; 24(5):397-401. PubMed ID: 11693538
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chemical genomics-based target identification and validation of anti-angiogenic agents.
    Kwon HJ
    Curr Med Chem; 2003 May; 10(9):717-36. PubMed ID: 12678774
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro antitumor and anti-angiogenic activities of a shrimp chondroitin sulfate.
    Palhares LCGF; Barbosa JS; Scortecci KC; Rocha HAO; Brito AS; Chavante SF
    Int J Biol Macromol; 2020 Nov; 162():1153-1165. PubMed ID: 32553958
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A potent gelatinase inhibitor with anti-tumor-invasive activity and its metabolic disposition.
    Lee M; Celenza G; Boggess B; Blase J; Shi Q; Toth M; Bernardo MM; Wolter WR; Suckow MA; Hesek D; Noll BC; Fridman R; Mobashery S; Chang M
    Chem Biol Drug Des; 2009 Feb; 73(2):189-202. PubMed ID: 19207421
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antioxidant and anti-protease activities of diazepinomicin from the sponge-associated Micromonospora strain RV115.
    Abdelmohsen UR; Szesny M; Othman EM; Schirmeister T; Grond S; Stopper H; Hentschel U
    Mar Drugs; 2012 Oct; 10(10):2208-2221. PubMed ID: 23170078
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Chemical Proteomic Analysis of Illudin-Interacting Proteins.
    Le P; Nodwell MB; Eirich J; Sieber SA
    Chemistry; 2019 Sep; 25(54):12644-12651. PubMed ID: 31310394
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antiangiogenic agents.
    Di Donna A
    Curr Pharm Des; 2010; 16(35):3862-3. PubMed ID: 21171950
    [No Abstract]   [Full Text] [Related]  

  • 59. Metal-catalyzed coupling/carbonylative cyclizations for accessing dibenzodiazepinones: an expedient route to clozapine and other drugs.
    Moutayakine A; Burke AJ
    Beilstein J Org Chem; 2024; 20():193-204. PubMed ID: 38318460
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Review of potential medical treatments for middle ear cholesteatoma.
    Schürmann M; Goon P; Sudhoff H
    Cell Commun Signal; 2022 Sep; 20(1):148. PubMed ID: 36123729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.